|
Mar 6
|
KalVista Pharmaceuticals to Participate in the Leerink Partners 2024 Global Biopharma Conference
|
|
Jan 13
|
Insider Sell: Chief Scientific Officer Edward Feener Sells 22,679 Shares of KalVista ...
|
|
Jan 12
|
Insider Sell: Chief Scientific Officer Edward Feener Sells 17,321 Shares of KalVista ...
|
|
Dec 30
|
Insider Sell: CEO Thomas Crockett Sells 30,000 Shares of KalVista Pharmaceuticals Inc (KALV)
|
|
Dec 29
|
16 Most Promising Long-Term Stocks According to Analysts
|
|
Dec 20
|
KalVista Pharmaceuticals Announces Publication of First Oral Factor XIIa Data in Frontiers in Pharmacology
|
|
Dec 7
|
KalVista Pharmaceuticals Inc (KALV) Reports Second Fiscal Quarter Results
|
|
Dec 7
|
KalVista Pharmaceuticals Reports Second Fiscal Quarter Results and Provides Operational Update
|
|
Dec 5
|
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
|
Apr 27
|
KalVista Pharmaceuticals to Present Data at the 13th C1-inhibitor Deficiency & Angioedema Workshop
|